BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Black Raspberries and Their Anthocyanin and Fiber Fractions Alter the Composition and Diversity of Gut Microbiota in F-344 Rats. ✅
Go to Publication ✅
Nutrition and cancer (Nutr Cancer ) Vol: 69 Issue 6 Pages: 943-951 Pub: 2017 Aug-Sep Epub: 2017 Jul 18 Authors Pan P , Lam V , Salzman N , Huang YW , Yu J , Zhang J , Wang LS , |
|
|
Dietary Administration of Black Raspberries and Arsenic Exposure: Changes in the Gut Microbiota and Its Functional Metabolites. ✅
Go to Publication ✅
Metabolites (Metabolites ) Vol: 13 Issue 2 Pages: Pub: 2023 Jan 30 Epub: 2023 Jan 30 Authors Tu P , Tang Q , Mo Z , Niu H , Hu Y , Wu L , Chen Z , Wang X , Gao B , |
|
|
Integrated 16s RNA sequencing and network pharmacology to explore the effects of polyphenol-rich raspberry leaf extract on weight control. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 10 Issue Pages: 1306037 Pub: 2023 Epub: 2024 Jan 8 Authors Wang T , Yang J , Huang Z , Wang F , Liu R , Liu Y , Li X , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
